GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Patients in historically redlined neighborhoods experience significantly longer delays in achieving HIV viral suppression ...

A New York doctor who treated HIV and AIDS patients sued Gilead for violating the False Claims Act with payments to doctors ...

If you support maintaining the U.S. approach to fighting HIV/AIDS, you should welcome the DOGE review to ensure that programs ...

Dozens of trials on HIV ground to a halt in February after US President Donald Trump abruptly pulled crucial funding.

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Demonstrators gathered Thursday on the steps of the Department of Health and Human Services (HHS) building for a “die-in” ...

A decade after Nigeria passed the HIV and AIDS Anti-Discrimination Act, experts say the promise of equality remains ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that ...